Announced Tue, 7 Jul · 17:53 IST
RTA confirms Reg 74(5) compliance; all shares held in demat form
Compliance View source PDF
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve
Awaiting price reaction for this filing.
AI summary
Clinitech Laboratory has submitted a routine quarterly disclosure under SEBI Regulation 74(5) for the quarter ended June 30, 2026. The company's Registrar and Transfer Agent, Bigshare Services, confirmed that the regulation is not applicable since all company shares are held in dematerialised form. No rematerialisation requests were received from any shareholder during the quarter. Filed by Chairman and Managing Director Jagdish Umakant Nayak.
Likely market impact
No material impact; purely procedural compliance filing with no effect on business or shareholders.